Biotech Innovations Propel Infectious Disease Testing Forward

(MENAFN- GlobeNewsWire - Nasdaq) The Molecular Diagnostics - Infectious Disease market offers opportunities driven by multiplex testing, biotechnology advances, and rapid testing. Factors such as pathogen evolution, globalization, and climate change boost growth. Innovations in nucleic acid and immunoassay promise advancements in diagnostics.

Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country with Market Analysis & Executive Guides" has been added to ResearchAndMarkets's offering.

The Molecular Diagnostics - Infectious Disease sector is on the brink of further expansion within the clinical diagnostics industry. This burgeoning market continues to grow, albeit with increasing complexity and segmentation. Discover insights from this comprehensive report, which explores the transformative impact of multiplex assays poised to revolutionize diagnosis and treatment.

Infectious disease testing is reaping considerable benefits from advancements in biotechnology, especially genomics. This report details the dynamic trends that are driving both market growth and company valuations, including:

• Multiplex testing
• Pathogen evolution and pandemics
• Advancements in genetic biotechnology
• Climate change
• Globalization
• The rise of rapid testing

Significant technical innovations, particularly in the interplay between nucleic acid testing and immunoassay, promise a rapidly evolving and expanding global market. These advances position diagnostics as a leader in the battle against infectious diseases.

The report spans hundreds of pages and includes a comprehensive list of Current United States Medicare Fee Payment Schedules, essential for refining pricing strategies, along with data on the most frequently used and billed tests. Detailed analyses for 15 countries and 4 regions are provided, with additional specific country breakouts available to report purchasers.

Companies Profiled

• Abbott Laboratories
• Agilent
• Altona Diagnostics
• Anitoa
• Autonomous Medical Devices
• Beckman Coulter Diagnostics (Danaher)
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioGX
• Biomatik
• bioMerieux Diagnostics
• Cepheid (Danaher)
• Diasorin S.p.A.
• DNAe
• Flow Health
• Global Access Diagnostics
• Great Basin Scientific, Inc.
• Hologic
• Novacyt
• Novus Diagnostics
• Oncimmune
• One Codex
• OraSure Technologies
• Prometheus Laboratories
• Qiagen
• QuidelOrtho
• R-Biopharm AG
• Response Biomedical
• Revvity
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• Vela Diagnostics
• Veredus Laboratories
• YD Diagnostics
• Zhejiang Orient Gene Biotech

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN11122025004107003653ID1110468509